Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Galmed Pharmaceuticals stock

Learn how to easily invest in Galmed Pharmaceuticals stock.

Galmed Pharmaceuticals is a biotechnology business based in the US. Galmed Pharmaceuticals shares (GLMD) are listed on the NASDAQ and all prices are listed in US Dollars. Galmed Pharmaceuticals employs 19 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Galmed Pharmaceuticals stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – GLMD. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance



  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Galmed Pharmaceuticals stock price (NASDAQ: GLMD)

Use our graph to track the performance of GLMD stocks over time.

Galmed Pharmaceuticals shares at a glance

Information last updated 2023-01-25.
Latest market close$0.67
52-week range$0.29 - $1.84
50-day moving average $0.48
200-day moving average $0.58
Wall St. target price$1.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.19

Buy Galmed Pharmaceuticals stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Galmed Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Galmed Pharmaceuticals price performance over time

Historical closes compared with the close of $0.671 from 2023-01-26

1 week (2023-01-20) -10.65%
1 month (2022-12-27) 24.26%
3 months (2022-10-27) 72.05%
6 months (2022-07-27) 31.57%
1 year (2022-01-27) -51.73%
2 years (2021-01-27) -81.31%
3 years (2020-01-27) 5.61
5 years (2018-01-26) 10.94

Galmed Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -43.53%
Return on equity TTM -84.9%
Profit margin 0%
Book value $0.63
Market capitalisation $17.4 million

TTM: trailing 12 months

Galmed Pharmaceuticals share dividends

We're not expecting Galmed Pharmaceuticals to pay a dividend over the next 12 months.

Galmed Pharmaceuticals share price volatility

Over the last 12 months, Galmed Pharmaceuticals's shares have ranged in value from as little as $0.29 up to $1.838. A popular way to gauge a stock's volatility is its "beta".

GLMD.US volatility(beta: 1.1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Galmed Pharmaceuticals's is 1.098. This would suggest that Galmed Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Galmed Pharmaceuticals overview

Galmed Pharmaceuticals Ltd. , a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a research agreement with Gannex Pharma Co. , Ltd.

Frequently asked questions

What percentage of Galmed Pharmaceuticals is owned by insiders or institutions?
Currently 13.875% of Galmed Pharmaceuticals shares are held by insiders and 11.419% by institutions.
How many people work for Galmed Pharmaceuticals?
Latest data suggests 19 work at Galmed Pharmaceuticals.
When does the fiscal year end for Galmed Pharmaceuticals?
Galmed Pharmaceuticals's fiscal year ends in December.
Where is Galmed Pharmaceuticals based?
Galmed Pharmaceuticals's address is: 16 Tiomkin Street, Tel Aviv, Israel, 6578317
What is Galmed Pharmaceuticals's ISIN number?
Galmed Pharmaceuticals's international securities identification number is: IL0011313900
What is Galmed Pharmaceuticals's CUSIP number?
Galmed Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: M47238106

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site